{
    "code": "52026249",
    "time": "2015-06-24 13:38:44",
    "許可證字號": "衛部藥輸字第026249號",
    "註銷狀態": "已註銷",
    "註銷日期": "103\/10\/08",
    "註銷理由": "自請註銷",
    "有效日期": "108\/02\/11",
    "發證日期": "103\/02\/11",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202624901",
    "中文品名": "克思癌微脂體注射劑2毫克\/毫升(鹽酸杜薩魯比辛)",
    "英文品名": "CASPRIA Liposome Injection 2mg\/ml (Doxorubicin Hydrochloride)",
    "適應症": "用於治療CD4數量低下(",
    "劑型": "270注射劑",
    "包裝": "10、25毫升玻璃小瓶裝 100支以下盒裝",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "DOXORUBICIN HCL",
    "限制項目": [
        "02輸入",
        "24監視期滿學名藥"
    ],
    "申請商名稱": "0929301100  美商默沙東藥廠股份有限公司台灣分公司",
    "申請商地址": "台北市信義區信義路五段106號12樓",
    "主製造廠": {
        "製造廠名稱": "F200416000  SUN PHARMACEUTICAL INDUSTRIES LTD.",
        "製造廠廠址": "HALOL - BARODA HIGHWAY, HALOL - 389 350, DIST. PANCHMAHAL, GUJARAT, INDIA",
        "製造廠公司地址": "",
        "製造廠國別": "INDIA",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1003000610",
            "成分名稱": "DOXORUBICIN HCL",
            "含量描述": "",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 0202624900001-103-04-09.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026249&Seq=001&Type=9"
        },
        {
            "title": "外盒 0202624900003-103-04-09.pdf 0202624900002-103-04-09.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026249&Seq=002&Type=8"
        }
    ]
}